Literature DB >> 31332293

Literature review and suggested protocol for prevention and treatment of corneal graft rejection.

Otavio Azevedo Magalhaes1, Ahmed Shalaby Bardan2,3, Mehran Zarei-Ghanavati4, Christopher Liu2,5.   

Abstract

Effective prophylaxis and treatment of corneal graft rejection are essential to improve outcomes in corneal transplantation. To date, there has been no standardized protocol published that outlines the optimal prophylactic and therapeutic approaches and, furthermore, the published controlled trials on this subject are limited. Likewise, no study has addressed how the level of antigen exposure varies between different types of keratoplasties. The aim of this paper is to provide a simple evidence-based protocol for the prevention and treatment of corneal graft rejection.

Entities:  

Mesh:

Year:  2019        PMID: 31332293      PMCID: PMC7042259          DOI: 10.1038/s41433-019-0517-9

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  57 in total

1.  Prevention and treatment of corneal graft rejection: current practice patterns (2004).

Authors:  J Bradley Randleman; R Doyle Stulting
Journal:  Cornea       Date:  2006-04       Impact factor: 2.651

2.  Stromal rejection following deep anterior lamellar keratoplasty: implications for postoperative care.

Authors:  Evan A Olson; Elmer Y Tu; Surendra Basti
Journal:  Cornea       Date:  2012-09       Impact factor: 2.651

3.  Opinions on risk factors and management of corneal graft rejection in the United kingdom.

Authors:  Peter Y P Koay; Weng Hon Lee; Francisco C Figueiredo
Journal:  Cornea       Date:  2005-04       Impact factor: 2.651

4.  Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011).

Authors:  Bhairavi Kharod-Dholakia; J Bradley Randleman; Jennifer G Bromley; R Doyle Stulting
Journal:  Cornea       Date:  2015-06       Impact factor: 2.651

Review 5.  Tomographic parameters for the detection of keratoconus: suggestions for screening and treatment parameters.

Authors:  Michael W Belin; Ovette F Villavicencio; Renato R Ambrósio
Journal:  Eye Contact Lens       Date:  2014-11       Impact factor: 2.018

6.  Efficacy of topical cyclosporine A 2% in prevention of graft rejection in high-risk keratoplasty: a randomized controlled trial.

Authors:  Rajesh Sinha; Vishal Jhanji; Kamna Verma; Namrata Sharma; Nihar R Biswas; Rasik B Vajpayee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

7.  The role of difluprednate ophthalmic emulsion in clinical practice.

Authors:  Karim N Jamal; David G Callanan
Journal:  Clin Ophthalmol       Date:  2009-06-29

8.  Survey of steroid usage patterns during and after low-risk penetrating keratoplasty.

Authors:  Francis W Price; David A Price; Vanessa Ngakeng; Marianne O Price
Journal:  Cornea       Date:  2009-09       Impact factor: 2.651

9.  Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty.

Authors:  Jasmeet S Dhaliwal; Benjamin F Mason; Stephen C Kaufman
Journal:  Cornea       Date:  2008-05       Impact factor: 2.651

10.  Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial.

Authors:  Alexander Poon; Marios Constantinou; Ecosse Lamoureux; Hugh R Taylor
Journal:  Clin Exp Ophthalmol       Date:  2008-07       Impact factor: 4.207

View more
  5 in total

Review 1.  Advances in corneal graft rejection.

Authors:  Jia Yin
Journal:  Curr Opin Ophthalmol       Date:  2021-07-01       Impact factor: 4.299

2.  Biodegradable silicon nanoneedles for ocular drug delivery.

Authors:  Woohyun Park; Van Phuc Nguyen; Yale Jeon; Bongjoong Kim; Yanxiu Li; Jonghun Yi; Hyungjun Kim; Jung Woo Leem; Young L Kim; Dong Rip Kim; Yannis M Paulus; Chi Hwan Lee
Journal:  Sci Adv       Date:  2022-03-30       Impact factor: 14.136

3.  Comparing the effectiveness of different postoperative counseling methods for post-keratoplasty patients.

Authors:  Venugopal Anitha; Shobita Nair; Meenakshi Ravindran; Mohammed Sithiq Uduman
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

Review 4.  Comment on: Stromal rejection in penetrating keratoplasty following COVID-19 vector vaccine (Covishield) - A case report and review of literature.

Authors:  Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

Review 5.  Corneal Transplant Rejections in Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Majid Moshirfar; Noor F Basharat; Tanner S Seitz; Briana K Ply; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  J Clin Med       Date:  2022-09-25       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.